Insider · CIK 0001767921

Ek John Frederick

Reports to the SEC for 2 companies · MARLBOROUGH, MA

sec.gov

Transactions

Companies

Filings

CIK

0001767921

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-08	Akoya Biosciences, Inc.Employee Stock Option (Right to Buy)J Other	CFO	JOther	−70K sh	—	—	0
2025-07-08	Akoya Biosciences, Inc.J Other	CFO	JOther	−54.5K sh	—	—	193,750
2025-07-08	Akoya Biosciences, Inc.J Other	CFO	JOther	−194K sh	—	—	0
2025-07-08	Akoya Biosciences, Inc.J Other	CFO	JOther	−20K sh	—	—	0
2025-07-08	Akoya Biosciences, Inc.Employee Stock Option (Right to Buy)J Other	CFO	JOther	−160K sh	—	—	0
2025-04-01	Akoya Biosciences, Inc.F Tax Payment	CFO	FTax Payment	−16.4K sh	$1.35	−$22.2K	248,202
2025-03-01	Akoya Biosciences, Inc.F Tax Payment	CFO	FTax Payment	−3,594 sh	$1.63	−$5,858.22	264,634
2024-11-19	Akoya Biosciences, Inc.A Award	CFO	AAward	+87.5K sh	—	—	268,228
2024-04-01	Akoya Biosciences, Inc.F Tax Payment	CFO	FTax Payment	−14.3K sh	$4.56	−$65.1K	180,728
2024-02-22	Akoya Biosciences, Inc.Employee Stock Option (Right to Buy)A Award	CFO	AAward	+70K sh	—	—	70,000
2024-02-22	Akoya Biosciences, Inc.A Award	CFO	AAward	+35K sh	—	—	195,000
2023-06-12	Akoya Biosciences, Inc.P Purchase	CFO	PPurchase	+20K sh	$5.00	+$100K	20,000
2023-03-20	Akoya Biosciences, Inc.Employee Stock Option (Right to Buy)A Award	CFO	AAward	+160K sh	—	—	160,000
2023-03-20	Akoya Biosciences, Inc.A Award	CFO	AAward	+160K sh	—	—	160,000
2021-04-22	GenMark Diagnostics, Inc.Market Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−46.7K sh	—	—	0
2021-04-22	GenMark Diagnostics, Inc.Market Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−30K sh	—	—	0
2021-04-22	GenMark Diagnostics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−17K sh	—	—	0
2021-04-22	GenMark Diagnostics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−17K sh	—	—	0
2021-04-22	GenMark Diagnostics, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−233K sh	$24.05	−$5.6M	0
2021-04-22	GenMark Diagnostics, Inc.Market Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−16.7K sh	—	—	0
2021-02-25	GenMark Diagnostics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−19.2K sh	—	—	232,993
2021-02-23	GenMark Diagnostics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−908 sh	—	—	252,241
2021-02-21	GenMark Diagnostics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−487 sh	—	—	253,149
2021-02-18	GenMark Diagnostics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,622 sh	—	—	208,636
2021-02-18	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+45K sh	—	—	253,636
2021-02-18	GenMark Diagnostics, Inc.Market Stock UnitsA Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2021-01-25	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−18.5K sh	$14.24	−$263K	210,258
2021-01-21	GenMark Diagnostics, Inc.Market Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−23.3K sh	—	—	23,333
2021-01-21	GenMark Diagnostics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+27.1K sh	—	—	205,399
2021-01-21	GenMark Diagnostics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+23.3K sh	—	—	228,733
2021-01-21	GenMark Diagnostics, Inc.Market Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−27.1K sh	—	—	8,333
2020-11-24	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,418 sh	$13.17	−$18.7K	178,284
2020-11-19	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,637 sh	$13.85	−$22.7K	179,702
2020-09-22	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−41.2K sh	$13.82	−$569K	181,339
2020-09-16	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−5,723 sh	$12.98	−$74.3K	222,535
2020-08-25	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,515 sh	$14.14	−$21.4K	228,258
2020-08-20	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−900 sh	$15.97	−$14.4K	231,464
2020-08-20	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,691 sh	$15.41	−$26.1K	229,773
2020-08-18	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−28.3K sh	$15.98	−$452K	232,364
2020-08-14	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−5,070 sh	$15.97	−$81K	260,671
2020-05-28	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,460 sh	$9.52	−$13.9K	265,741
2020-05-19	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,648 sh	$10.46	−$17.2K	267,201
2020-02-27	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,040 sh	$3.51	−$3,650.4	268,849
2020-02-25	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+52.5K sh	—	—	270,405
2020-02-25	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+52.5K sh	—	—	217,905
2020-02-25	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−516 sh	$3.81	−$1,965.96	269,889
2020-02-25	GenMark Diagnostics, Inc.Market Stock UnitsA Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000
2020-02-20	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−8,848 sh	$3.80	−$33.6K	165,405
2020-01-21	GenMark Diagnostics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,216 sh	—	—	177,006
2020-01-21	GenMark Diagnostics, Inc.Market Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,216 sh	—	—	18,784

Recent filings

Accepted (ET)
Jul 104
Ek John Frederick0001062993-25-012728
SEC(opens sec.gov)
Apr 34
Ek John Frederick0001062993-25-006998
SEC(opens sec.gov)
Mar 44
Ek John Frederick0001062993-25-004359
SEC(opens sec.gov)
Nov 214
Ek John Frederick0001062993-24-019524
SEC(opens sec.gov)
Apr 24
Ek John Frederick0001104659-24-042562
SEC(opens sec.gov)
Mar 14
Ek John Frederick0001104659-24-030176
SEC(opens sec.gov)
Jun 124
Ek John Frederick0001104659-23-070485
SEC(opens sec.gov)
Mar 214
Ek John Frederick0001104659-23-035178
SEC(opens sec.gov)
Apr 224
Ek John Frederick0001487371-21-000167
SEC(opens sec.gov)

Companies

Address

C/O AKOYA BIOSCIENCES, INC. 100 CAMPUS DRIVE, 6TH FLOOR

MARLBOROUGH, MA, 01752